Evidence map›Paper›PMID 32880829›Full record

ReviewMycopathologia2020

Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.

Ramírez-Sanchez Isabel Cristina, Agredo Diana, Arango Karen

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. The first suspected disseminatedEmerging microbes & infections · 2023
    Article
  4. Successful Treatment of Rare PulmonaryInfection and drug resistance · 2023
    Article
  5. InvasiveAnnals of laboratory medicine · 2022
    Article
  6. InvasiveMedical mycology case reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ramírez-Sanchez Isabel CristinaInfectious Diseases Section, Internal Medicine Department, Hospital Pablo Tobón Uribe, Universidad de Antioquia Medical School, calle 78B#69-240, Medellín, Colombia. iramirez@hptu.org.co.ORCID http://orcid.org/0000-0003-4698-1871
Agredo DianaInfectious Diseases Section, Internal Medicine Department, Universidad de Antioquia Medical School, Medellín, Colombia.
Arango KarenUnidad de Micología Medica y Experimental, Corporación Para Investigaciones Biológicas, Universidad de Antioquia, Universidad Pontificia Bolivariana, Medellín, Colombia.
Universidad de Antioquia · COUniversidad Pontificia Bolivariana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breakthrough invasive infections occur in immunosuppressed patients while they are receiving antifungal agents for both prophylaxis and therapy. Under such conditions, unusual fungal infections emerge. Hormographiella aspergillata is considered an uncommon human pathogen and causes devastating infections. Here, we present a case report of necrotizing pneumonia caused by H. aspergillata as a breakthrough infection in a neutropenic patient and review all previous cases of H. aspergillata infection reported in the literature.

Indexed as

Antifungal AgentsLeukemia, Myeloid, AcuteAgaricalesHumansMycosesPneumonia, NecrotizingTriazolesAntifungal AgentsposaconazoleTriazolesAntifungalBreakthroughHormographiella aspergillataPneumoniaPosaconazoleProphylaxis

Identifiers

PMID32880829
OpenAlexW3083354590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.